4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-014538
Director acquired 2,814 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-10-17 | Other acquisition 10b5-1 | +280 | $2.24 | $627 | 222,473 | D |
| Krogulski Kenneth Director | 2023-10-18 | Other acquisition 10b5-1 | +280 | $1.96 | $549 | 222,753 | D |
| Krogulski Kenneth Director | 2023-10-19 | Other acquisition 10b5-1 | +280 | $2.05 | $574 | 223,033 | D |
| Krogulski Kenneth Director | 2023-10-20 | Other acquisition 10b5-1 | +64 | $2.08 | $133 | 223,097 | D |
| Krogulski Kenneth Director | 2023-10-23 | Other acquisition 10b5-1 | +255 | $2.08 | $530 | 223,352 | D |
| Krogulski Kenneth Director | 2023-10-24 | Other acquisition 10b5-1 | +280 | $2.10 | $588 | 223,632 | D |
| Krogulski Kenneth Director | 2023-10-25 | Other acquisition 10b5-1 | +280 | $1.99 | $557 | 223,912 | D |
| Krogulski Kenneth Director | 2023-10-26 | Other acquisition 10b5-1 | +280 | $1.99 | $557 | 224,192 | D |
| Krogulski Kenneth Director | 2023-10-27 | Other acquisition 10b5-1 | +280 | $1.98 | $554 | 224,472 | D |
| Krogulski Kenneth Director | 2023-10-30 | Other acquisition 10b5-1 | +255 | $2.04 | $520 | 224,727 | D |
| Krogulski Kenneth Director | 2023-10-31 | Other acquisition 10b5-1 | +280 | $2.01 | $563 | 225,007 | D |
Loading xslF345X05/marketforms-63457.xml…